1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Industry Market Research Reports 2021 - Europe

Chronic Disease Industry Market Research Reports 2021 - Europe

Customer Support

Talk to Sam

+1 718 303 2384

All regions

1-30 of about 500 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Integrity Applications, Inc. Quarterly report

  • November 2021
  • 15 pages
  • United States
  • World
  • Diabetes
  • Research And Development
  • Quarterly report
  • Company
  • Diabetes Prevalence
  • Property Sales
View report >

Nemaura Medical Quarterly report

  • November 2021
  • 19 pages
  • United Kingdom
  • United States
  • Pharmaceutical
  • Healthcare
  • Quarterly report
  • Company
  • Employment Income
View report >

InspireMD Quarterly report

  • November 2021
  • 20 pages
  • United States
  • World
  • Research And Development
  • Business Services
  • Quarterly report
  • Company
  • Employment Costs
  • Property Sales
View report >

Galapagos Investor presentation

  • November 2021
  • 19 pages
  • Europe
  • Research And Development
  • Drug Development
  • Investor presentation
  • Company
View report >

Amphastar Investor presentation

  • November 2021
  • 26 pages
  • United States
  • France
  • Biosimilar
  • Research And Development
  • Investor presentation
  • Company
View report >

Amphastar Investor presentation

  • November 2021
  • 26 pages
  • United States
  • France
  • Biosimilar
  • Research And Development
  • Investor presentation
  • Company
View report >

Vicore Pharma Investor presentation

  • November 2021
  • 31 pages
  • World
  • Europe
  • Respiratory Disease
  • Investor presentation
  • Company
  • Drug Approval
  • Life Expectancy
View report >

Idorsia Company report

  • October 2021
  • 7 pages
  • United States
  • World
  • Hospital
  • Neurological Disorder
  • Company research
  • Company
View report >

Uscom Quarterly report

  • October 2021
  • 8 pages
  • Russia
  • World
  • Heart Failure
  • Cardiovascular Disease
  • Quarterly report
  • Company
View report >

Galapagos Investor presentation

  • October 2021
  • 34 pages
  • Europe
  • Renal Disease
  • Investor presentation
  • Company
View report >

Uscom Quarterly report

  • October 2021
  • 9 pages
  • World
  • Russia
  • Heart Failure
  • Cardiovascular Disease
  • Quarterly report
  • Company
View report >

DBV Technologies Quarterly report

  • September 2021
  • 7 pages
  • France
  • World
  • Food Allergy
  • Clinical Trial
  • Quarterly report
  • Company
View report >

Kancera AB Half year report

  • September 2021
  • 22 pages
  • European Union
  • Drug Development
  • Clinical Trial
  • Interim report
  • Company
  • Number Of Employees
View report >

Nexstim Investor presentation

  • September 2021
  • 11 pages
  • World
  • United States
  • Diagnostics
  • Healthcare
  • Investor presentation
  • Company
View report >

Auris Medical Investor presentation

  • September 2021
  • 14 pages
  • United States
  • Europe
  • Allergy
  • Investor presentation
  • Company
  • Mortality Rate
View report >

Allergy Therapeutics Annual report

  • September 2021
  • 28 pages
  • Europe
  • World
  • Pharmaceutical
  • Therapy
  • Annual report
  • Company
  • Greenhouse Gas Emissions
View report >

Allergy Therapeutics Annual report

  • September 2021
  • 22 pages
  • Europe
  • World
  • Pharmaceutical
  • Allergy
  • Annual report
  • Company
  • Greenhouse Gas Emissions
View report >

Santhera Pharmaceuticals Quarterly report

  • September 2021
  • 5 pages
  • United States
  • North America
  • Private Placement
  • Respiratory Disease
  • Quarterly report
  • Company
View report >

CARMAT Analyst report

  • September 2021
  • 5 pages
  • Europe
  • United States
  • Financial Services
  • Heart Failure
  • Broker research
  • Company
View report >

Mayo Clinic Investor presentation

  • September 2021
  • 16 pages
  • World
  • United States
  • Heart Failure
  • Investor presentation
  • Company
  • Electronic Component Production
  • Drug Approval
View report >

Voluntis Quarterly report

  • September 2021
  • 5 pages
  • France
  • United States
  • Therapy
  • Chronic Disease
  • Quarterly report
  • Company
View report >

ReWalk Robotics Investor presentation

  • September 2021
  • 25 pages
  • United States
  • Germany
  • Stroke
  • Neurological Disorder
  • Investor presentation
  • Company
View report >

Can-Fite BioPharma Company report

  • August 2021
  • 7 pages
  • Europe
  • China
  • Infectious Disease
  • Arthritis
  • Company research
  • Company
View report >

Cyclopharm Limited Half year report

  • August 2021
  • 32 pages
  • World
  • Australia
  • Electric Generator
  • Respiratory Disease
  • Interim report
  • Company
  • Electric Generator Sales
  • Medical Devices Sales
View report >

Integrity Applications, Inc. Quarterly report

  • August 2021
  • 14 pages
  • United States
  • World
  • Diabetes
  • Diabetes Monitoring
  • Quarterly report
  • Company
  • Diabetes Prevalence
  • Property Sales
View report >

Nemaura Medical Quarterly report

  • August 2021
  • 17 pages
  • United Kingdom
  • United States
  • Research And Development
  • Healthcare
  • Quarterly report
  • Company
  • Employment Income
View report >

Nexstim Half year report

  • August 2021
  • 21 pages
  • Finland
  • Northern Europe
  • Depression
  • Diagnostics
  • Interim report
  • Company
  • Number Of Enterprises
  • Health Provider Density
View report >

Galapagos Quarterly report

  • August 2021
  • 7 pages
  • Europe
  • World
  • Arthritis
  • Drug Development
  • Quarterly report
  • Company
View report >

Vicore Pharma Investor presentation

  • August 2021
  • 31 pages
  • World
  • United States
  • Respiratory Disease
  • Investor presentation
  • Company
  • Drug Approval
  • Life Expectancy
View report >

Diamyd Medical Half year report

  • August 2021
  • 14 pages
  • Sweden
  • Type 1 Diabetes
  • Interim report
  • Company
1 report

Purchase Reports From Reputable Market Research Publishers

AtriCure Inc (ATRC) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 39 pages

Summary AtriCure Inc (AtriCure) is a provider of medical devices for the treatment of atrial fibrillation (Afib) and related conditions.The company develops, manufacture and sale of cardiac surgical ablation ...

  • United States
  • Europe
  • Cardiovascular Disease
  • Clinical Trial
  • Investor presentation
  • Company
  • Drug Approval
  • Medical Devices Sales

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on